Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Renhuang CEO Li Shaoming On Growing Traditional Chinese Medicine Business In China: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

Renhuang CEO Li Shaoming recently spoke with PharmAsia News' Shanghai bureau about the Chinese TCM market, the impact of current government policies and the effect of the Sichuan earthquake on drug makers. Founded in 1996 in Harbin, Heilongjiang province, Renhuang Pharmaceuticals provides three major product lines, including Siberian ginseng-based natural medicinal products, biopharmaceutical products and traditional Chinese medicines. In September 2006, Renhuang became a public company in the United States through a reverse merger, and it is currently traded on NASDAQ as OTCBB.

You may also be interested in...



Medical Insurance Plan Expected To Boost Size Of China Pharma Market

SHANGHAI - China's basic medical insurance program will cover all urban residents in the country by the end of this year, the State Council of China announced recently

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

ID1131516

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel